Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine for Total Shoulder Arthroplasty
NCT03587636Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Sep 2018
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by University of Minnesota. Primary endpoint: Total Opioid Use at 72 hours. Started Sep 2018; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03587636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03587636.